Loading...
Docoh

75 results

Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
10-K
2021 FY
EX-10.13
INTI Inhibitor Therapeutics, Inc.
30 Mar 22
Annual report
9:01am
8-K
EX-10.1
INTI Inhibitor Therapeutics, Inc.
18 Jan 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.1
INTI Inhibitor Therapeutics, Inc.
17 Dec 20
Entry into a Material Definitive Agreement
5:02pm
8-K
EX-10.1
INTI Inhibitor Therapeutics, Inc.
6 May 20
Entry into a Material Definitive Agreement
4:32pm
10-Q
2019 Q3
EX-10.1
INTI Inhibitor Therapeutics, Inc.
7 Nov 19
Quarterly report
4:34pm
10-K
EX-10.5
95f90vixs78yvud3p
7 Mar 19
Annual report
9:01am
10-K
EX-10.6
z1xxutacdh3bb2twcj
7 Mar 19
Annual report
9:01am
10-K
EX-10.7
ne930 3yzx
7 Mar 19
Annual report
9:01am
8-K
EX-10.2
a1t oqly62zodjdyr1
31 Dec 18
Entry into a Material Definitive Agreement
5:16pm
8-K
EX-10.1
11tphc2ksfh4fjls6ork
31 Dec 18
Entry into a Material Definitive Agreement
5:16pm
8-K
EX-10.1
2kms1sb23b9mvq
11 Jan 18
HedgePath Pharmaceuticals Secures New Funding from Mayne Pharma to Support BCCNS Clinical and Regulatory Approval Programs
12:00am
8-K
EX-10.2
ken694wr
11 Jan 18
HedgePath Pharmaceuticals Secures New Funding from Mayne Pharma to Support BCCNS Clinical and Regulatory Approval Programs
12:00am
10-K
EX-10.6
fn70lmkeg lbflu73m
17 Feb 17
Annual report
12:00am
10-K
EX-10.11
8v93hxycbtyz
17 Feb 17
Annual report
12:00am
10-K
EX-10.16
bpav9m0lto
17 Feb 17
Annual report
12:00am
8-K
EX-10.1
x492qs0n8n8lukz0bc
15 Apr 16
Entry into a Material Definitive Agreement
12:00am
S-1/A
EX-10.21
sj4f5etc 65d
23 Feb 16
IPO registration (amended)
12:00am
8-K
EX-10.1
d55461
22 Dec 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
qvnktpnei6i7
9 Sep 15
Entry into a Material Definitive Agreement
12:00am
10-Q
EX-10.2
pfwguvpmn8cr3sk6
14 Aug 15
Quarterly report
12:00am